🔗 Permalink

Inventor profile of:

John Edward PARK

City:

Warthausen

Country:

Germany

Published Applications:

Last publication date:

2024-01-04

Top Assignees for applications by John Edward PARK

The entities that hold a legal rights for patent applications filed by inventor PARK John Edward:

BOEHRINGER INGELHEIM INTERNATIONAL GMBH 10 Ingelheim am Rhein, Germany
ViraTherapeutics GmbH 1 Rum, Austria
Boehringer Igelheim International GmbH 1 Ingelheim am Rhein, Germany

Recent patent applications by PARK John Edward

John Edward PARK from Warthausen, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-01-04

US20240000874A1

Human necessities

RECOMBINANT RHABDOVIRUS ENCODING FOR CCL21

#2 | 2023-11-23

US20230372297A1

Human necessities

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

#3 | 2020-10-22

US20200330435A1

Human necessities

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

#4 | 2020-07-30

US20200237838A1

Human necessities

Recombinant rhabdovirus encoding for CCL21

#5 | 2019-02-07

US20190038600A1

Human necessities

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DEISEASES

#6 | 2016-05-19

US20160136133A1

Human necessities

Medicaments for the treatment or prevention of fibrotic diseases

#7 | 2015-07-30

US20150210778A1

Chemistry; metallurgy

ANTICOAGULANT ANTIDOTES

#8 | 2014-10-02

US20140296217A1

Chemistry; metallurgy

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

#9 | 2014-05-08

US20140128409A1

Human necessities

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

#10 | 2013-10-31

US20130289248A1

Chemistry; metallurgy

Methods of using antibodies during anticoagulant therapy of dabigatran and/or related compounds

#11 | 2012-02-02

US20120027780A1

Chemistry; metallurgy

Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compounds

#12 | 2012-01-05

US20120004202A1

Human necessities

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

#13 | 2011-03-31

US20110076238A1

Human necessities

COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE PROCESSES

#14 | 2010-08-12

US20100204211A1

Human necessities

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

InventorID:

510086 ⎘